Correlation Between Moderna and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Moderna and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moderna and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moderna and Vertex Pharmaceuticals Incorporated, you can compare the effects of market volatilities on Moderna and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moderna with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moderna and Vertex Pharmaceuticals.
Diversification Opportunities for Moderna and Vertex Pharmaceuticals
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Moderna and Vertex is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Moderna and Vertex Pharmaceuticals Incorpo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Moderna is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moderna are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Moderna i.e., Moderna and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Moderna and Vertex Pharmaceuticals
Assuming the 90 days horizon Moderna is expected to under-perform the Vertex Pharmaceuticals. In addition to that, Moderna is 5.95 times more volatile than Vertex Pharmaceuticals Incorporated. It trades about -0.1 of its total potential returns per unit of risk. Vertex Pharmaceuticals Incorporated is currently generating about 0.5 per unit of volatility. If you would invest 37,500 in Vertex Pharmaceuticals Incorporated on October 21, 2024 and sell it today you would earn a total of 3,615 from holding Vertex Pharmaceuticals Incorporated or generate 9.64% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Moderna vs. Vertex Pharmaceuticals Incorpo
Performance |
Timeline |
Moderna |
Vertex Pharmaceuticals |
Moderna and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Moderna and Vertex Pharmaceuticals
The main advantage of trading using opposite Moderna and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moderna position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.The idea behind Moderna and Vertex Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Vertex Pharmaceuticals vs. HEMISPHERE EGY | Vertex Pharmaceuticals vs. UPDATE SOFTWARE | Vertex Pharmaceuticals vs. X FAB Silicon Foundries | Vertex Pharmaceuticals vs. TELECOM ITALRISP ADR10 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |